ACE	angiotensin-converting enzyme inhibitors
AII	angiotensin II
APKD	autosomal polycystic kidney disease
AS	alport syndrome
ASO	antisense oligonucleotide
ATP	adenosine triphosphate
CKD	chronic kidney disease
COL4A5	collagen IV alpha-5-chain
ccRCC	clear cell renal cell carcinoma
DMPK	disposition, metabolism and pharmacokinetics
ECM	extracellular matrix
EMA	european medicines agency
FDA	federal drug administration
GFR	glomerular filtration frate
GLUT1	glucose uptake transporter 1
HIF	hypoxia inducible factor
ICI	immune check-point inhibitors
IL-6	interleukin-6
ITF	intra tumor fibrosis
miRNA	micro ribonucleic acid
mRNA	messenger ribonucleic acid
mTOR	mammalian target of rapamycin
Na/K-ATPase	sodium/potassium ATPase
NF-kB	nuclear factor-kappa B
NGAL	neutrophil gelatinase-associated lipocalin
NRF2	nuclear factor erythroid 2-related factor 2
PHD	prolyl hydroxylase
PROTAC	proteolysis targeting chimeras
RCC	renal cell carcinoma
RPTEC	renal proximal tubule epithelial cells
SLGT2	sodium glucose transport protein 2
TGF-β	transforming growth factor beta
TKI	tyrosine kinase inhibitor